Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 34, Issue 1, 2016, Pages 25-31

  Guggino, Giuliana ^a   Ciccia, Francesco ^a   Raimondo, Stefania ^a   Giardina, Giuseppina ^a   Alessandro, Riccardo ^a   Dieli, Francesco ^a   Sireci, Guido ^a   Triolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Autoantibodies; B cells; iNKT cells; Sj gren's syndrome

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; AUTOANTIBODY; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; RO ANTIBODY; ANTINUCLEAR ANTIBODY; IFNG PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; SS-A ANTIBODIES; VALPHA24 PROTEIN, HUMAN;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MINOR SALIVA GLAND; NATURAL KILLER T CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SIALOADENITIS; SJOEGREN SYNDROME; BIOPSY; BIOSYNTHESIS; CASE CONTROL STUDY; CELL COMMUNICATION; CELL CULTURE; CELL PROLIFERATION; COCULTURE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SJOGREN'S SYNDROME;

ANTIBODIES, ANTINUCLEAR; ANTIBODY FORMATION; B-LYMPHOCYTES; BIOPSY; CASE-CONTROL STUDIES; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; NATURAL KILLER T-CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84958811684     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. VOULGARELIS M, TZIOUFAS AG: Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010; 6: 529-37.
2. CHRISTODOULOU MI, KAPSOGEORGOU EK, MOUTSOPOULOS HM: Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun 2010; 34: 400-7.
3. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001; 44: 1127-38.
4. CHO YN, KEE SJ, LEE SJ et al.: Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. Rheumatology (Oxford) 2011; 50: 1054-63.
5. BENDELAC AP, SAVAGE B, TEYTON L: The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
6. BRIGL M, BRENNER MB: CD1: antigen presentation and T cell function. Annu Rev Immunol 2004; 22: 817-90.
7. MATSUDA JL, NAIDENKO OV, GAPIN L et al.: Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000; 192: 741-54.
8. HOLZAPFEL KL, TYZNIK AJ, KRONENBERG M, HOGQUIST KA: Antigen-dependent versus -independent activation of invariant NKT cells during infection. J Immunol 2014; 192:5490-8.
9. CARDELL SL: The natural killer T lymphocyte:a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin Exp Immunol 2006; 143: 194-202.
10. LANG GA, EXLEY MA, LANG ML: The CD1dbinding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 2006; 119:116-25.
11. YANG JQ, WEN X, KIM PJ, SINGH RR: Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner. J Immunol 2011; 186: 1512-20.
12. WERMELING F, LIND SM, JORDÖ ED, CARDELL SL, KARLSSON MC: Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J Exp Med 2010; 207: 943-52.
13. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
14. CICCIA F, GUGGINO G, RIZZO A et al.: Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome. Ann Rheum Dis 2012; 71: 295-301.
15. AQRAWI LA, SKARSTEIN K, ØIJORDSBAKKEN G, BROKSTAD KA: Ro52-and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome. Clin Exp Immunol 2013; 172: 228-37.
16. MAJOR AS, SINGH RR, JOYCE S, Van KAER L: The role of invariant natural killer T cells in lupus and atherogenesis. Immunol Res 2006; 34: 49-66.
17. Di PIETRO C, FALCONE M: The role of invariant NKT cells in organ-specific autoimmunity. Front Biosci (Landmark Ed) 2014; 19: 1240-50.
18. AWADA A, NICAISE C, ENA S et al.: Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjögren's syndrome. Ann Rheum Dis 2014; 73: 1259-63.
19. + CD4-CD8-T cells. J Exp Med 1997; 186: 109-20.
20. SALOMONSSON S, JONSSON MV, SKARSTEIN K et al.: Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003; 48: 3187-201.
21. LIUBCHENKO GA, APPLEBERRY HC, HOLERS VM, BANDA NK, WILLIS VC, LYUBCHENKO T: Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile. J Autoimmun 2012; 38: 293-303.